Covenant Multifamily Offices’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Covenant Multifamily Offices's BMY Position: Q3 2021 in Review
Covenant Multifamily Offices increased its Bristol-Myers Squibb (BMY) stake by 7.8% in Q3 2021, buying an estimated $76.5K and bringing the position to 16,003 shares worth $947K. The position accounts for 0.17% of the portfolio, ranked #90.
Covenant Multifamily Offices first reported a position in BMY in Q1 2021 and has held it in 3 quarters since. The position peaked at $992K in Q2 2021. 2,293 funds tracked by Wall St. Rank hold BMY as of Q3 2021.
- Covenant Multifamily Offices held 16,003 shares of Bristol-Myers Squibb worth $947K as of Q3 2021.
- Covenant Multifamily Offices bought 1,162 Bristol-Myers Squibb shares in Q3 2021, an estimated $76.5K.
- Bristol-Myers Squibb made up 0.17% of Covenant Multifamily Offices's portfolio in Q3 2021, its #90 holding.
- Covenant Multifamily Offices first reported a position in Bristol-Myers Squibb in Q1 2021 and has held it in 3 quarters since.
- Covenant Multifamily Offices's Bristol-Myers Squibb position peaked at $992K in Q2 2021.
- 2,293 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2021.
Based on Covenant Multifamily Offices's 13F filing for Q3 2021, filed 21 Oct 2021.